TNF and rheumatoid arthritis: In a multicenter, retrospective study, 145 RA patients initially treated with tocilizumab (most of them discontinued tocilizumab due to lack of effectiveness) were switched to TNF inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab), abatacept or JAK inhibitors.